[Department of Error] Department of Error
Papi A, Vestbo J, Fabbri L, et al. Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial. Lancet 2018; 391: 1076–84—In figure 3B of this Article (published online first on Feb 8, 2018), the y-axis title and the “Adjusted mean difference between treatments” heading have been corrected. This correction has been made to the online version as of Feb 26, 2018, and the printed Article is correct.